Detalhe da pesquisa
1.
Targeted and global pharmacometabolomics in everolimus-based immunosuppression: association of co-medication and lysophosphatidylcholines with dose requirement.
Metabolomics
; 14(1): 3, 2017 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30830337
2.
Influence of CYP3A5 genetic variation on everolimus maintenance dosing after cardiac transplantation.
Clin Transplant
; 29(12): 1213-20, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26458301
3.
Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients.
BMC Infect Dis
; 15: 582, 2015 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26703239
4.
CYP3A5*3 and POR*28 genetic variants influence the required dose of tacrolimus in heart transplant recipients.
Ther Drug Monit
; 36(6): 710-5, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24739669
5.
Heart rate kinetics during standard cardiopulmonary exercise testing in heart transplant recipients: a longitudinal study.
ESC Heart Fail
; 8(2): 1096-1105, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33417294
6.
Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography.
PLoS One
; 13(8): e0202950, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30148864
7.
Circulating oxidized low-density lipoprotein is associated with echolucent plaques in the femoral artery independently of hsCRP in 61-year-old men.
Atherosclerosis
; 190(1): 187-93, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16494881
8.
[More heart transplantations than ever]. / Fler hjärttransplantationer än någonsin.
Lakartidningen
; 109(39-40): 1743-4, 2012.
Artigo
em Sueco
| MEDLINE | ID: mdl-23097880
9.
Preclinical atherosclerosis and inflammation in 61-year-old men with newly diagnosed diabetes and established diabetes.
Diabetes Care
; 27(4): 880-4, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15047642
10.
[Better and better results of heart transplantation. Analysis of 25 years of collected experiences]. / Resultaten av hjärttransplantation allt bättre Analys av 25 ars samlade erfarenheter.
Lakartidningen
; 106(49): 3332-7, 2009.
Artigo
em Sueco
| MEDLINE | ID: mdl-20104731
11.
Plasma NGAL and glomerular filtration rate in cardiac transplant recipients treated with standard or reduced calcineurin inhibitor levels.
Biomark Med
; 8(2): 239-45, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24521021
12.
Everolimus immunosuppression in de novo heart transplant recipients: what does the evidence tell us now?
Transplant Rev (Orlando)
; 27(3): 76-84, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23643624
13.
Endothelial cell antibody-mediated rejection and successful retransplantation in a heart transplanted patient.
Eur J Cardiothorac Surg
; 42(6): 1044-6, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22912436
14.
Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies.
J Heart Lung Transplant
; 31(12): 1276-80, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23089300
15.
Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate.
J Heart Lung Transplant
; 31(3): 259-65, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22333403